The Omicron variant of severe acute respiratory syndrome coronavirus 2 is a new variant of
concern (VOC) and an emerging subvariant that exhibits heightened infectivity …

Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

Chronic kidney disease affects more than 800 million people worldwide and often
progresses to end-stage renal disease, which requires maintenance dialysis. Patients …

Background Kidney disease is a key risk factor for COVID-19-related mortality and
suboptimal vaccine response. Optimising vaccination strategies is essential to reduce the …

Data on immune responses following COVID-19 booster vaccinations and subsequent
infections in the immunocompromised are limited. We studied antibody responses after the …

Objectives Globally, over 772 million cases of COVID-19 have been reported. New variants
of interest with corresponding spikes in case numbers continue to be identified. Vulnerable …

Vaccinating patients receiving dialysis may prevent morbidity and mortality in this vulnerable
population. The National Forum of End-Stage Renal Disease Networks (the Forum) …

Healthy individuals with hybrid immunity, due to a SARS-CoV-2 infection prior to first
vaccination, have stronger immune responses compared to those who were exclusively …

Background: Kidney transplant recipients (KTRs) who have a highly impaired immune
response are in need of intensified and safe vaccination strategies to achieve …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has negatively impacted
on patients of the whole CKD spectrum, causing high rates of morbi-mortality. SARS-CoV-2 …